Insulet Installs Solar Panels at Its Global Headquarters and U.S. Manufacturing Facility to Help Reduce Its Carbon Footprint
Summary
“We understand our responsibility to help protect the environment and this is another important step toward reducing our carbon footprint,” said Chuck Alpuche, Executive Vice President and Chief Operating Officer. “We are continuously looking to establish and enhance our environmentally and socially responsible best practices as we improve our sustainability measures and focus on our long-term goals.” Insulet’s solar installation has an energy capacity of 900 kilowatts, enough to power 30 average-sized U.S. homes daily. The Company’s U.S. manufacturing facility began producing sellable product in May 2019 and, among many other strategic benefits, added supplier capabilities closest to its largest customer base and further reduced its carbon footprint. Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.